NorthWest Biotherapeutics Inc (NWBO)

[10baggerz]

100% agree, and unless they’ve had no plan whatsoever for the past 2 years and are simply desperate for financing, they probably won’t sell these preferred shares at $16.xx (.64 common).

Still, IF there isn’t news in the premarket, the timing of this filing is yet another befuddling action by management (akin to not updating clinical trials before 5/10). We are near a 100 week closing low, we desperately need good news for any sustainable share price increase and what do they do?

Pre-dilute 250,000,000 shares that have not even been authorized yet by shareholders. One thing is for sure, tomorrow will NOT be another low volume walk down day.